Cite
Wu LW, Pavlock T, Patterson A, et al. Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an . JCO Precis Oncol. 2018;2doi: 10.1200/PO.18.00101.
Wu, L. W., Pavlock, T., Patterson, A., Post, A., Ambrose, C., Rajaram, V., Pavlick, D. C., Cooke, M., Miller, V. A., Albacker, L. A., Ali, S. M., Smith, S., Cox, M. C., Martin, A., Megison, S., & Laetsch, T. W. (2018). Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an . JCO precision oncology, 2. https://doi.org/10.1200/PO.18.00101
Wu, Lawrence W, et al. "Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an ." JCO precision oncology vol. 2 (2018). doi: https://doi.org/10.1200/PO.18.00101
Wu LW, Pavlock T, Patterson A, Post A, Ambrose C, Rajaram V, Pavlick DC, Cooke M, Miller VA, Albacker LA, Ali SM, Smith S, Cox MC, Martin A, Megison S, Laetsch TW. Durable Clinical Response to Larotrectinib in an Adolescent Patient With an Undifferentiated Sarcoma Harboring an . JCO Precis Oncol. 2018 Aug 02;2. doi: 10.1200/PO.18.00101. eCollection 2018. PMID: 32913990; PMCID: PMC7446438.
Copy
Download .nbib